{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:19:44Z","timestamp":1788221984593,"version":"build-2803163510"},"reference-count":50,"publisher":"The Journal of Rheumatology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The incidence of inflammatory bowel disease (IBD) in juvenile idiopathic arthritis (JIA) is higher than in the general pediatric population. However, reports of IBD in the systemic JIA (sJIA) subtype are limited. We sought to characterize sJIA patients diagnosed with IBD and to identify potential contributing risk factors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Using an internationally distributed survey, we identified 16 patients with sJIA who were subsequently diagnosed with IBD (sJIA-IBD cohort). Five hundred twenty-two sJIA patients without IBD were identified from the CARRA Legacy Registry and served as the sJIA-only cohort for comparison. Differences in demographic, clinical characteristics, and therapy were assessed using chi-square test, Fisher exact test,<jats:italic>t<\/jats:italic>-test, and univariate and multivariate logistic regression, as appropriate.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the patients with sJIA-IBD, 75% had a persistent sJIA course and 25% had a history of macrophage activation syndrome. sJIA-IBD subjects were older at sJIA diagnosis, more often non-White, had a higher rate of IBD family history, and were more frequently treated with etanercept or canakinumab compared to sJIA-only subjects. Sixty-nine percent of sJIA-IBD patients successfully discontinued sJIA medications following IBD diagnosis, and sJIA symptoms resolved in 9 of 12 patients treated with tumor necrosis factor-\u03b1 (TNF-\u03b1) inhibitors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>IBD in the setting of sJIA is a rare occurrence. The favorable response of sJIA symptoms to therapeutic TNF-\u03b1 inhibition suggests that the sJIA-IBD cohort may represent a mechanistically distinct sJIA subgroup. Our study highlights the importance of maintaining a high level of suspicion for IBD when gastrointestinal involvement occurs in patients with sJIA and the likely broad benefit of TNF-\u03b1 inhibition in those cases.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.200230","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T16:19:37Z","timestamp":1592237977000},"page":"567-574","source":"Crossref","is-referenced-by-count":15,"title":["Inflammatory Bowel Disease in Children With Systemic Juvenile Idiopathic Arthritis"],"prefix":"10.3899","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6930-7375","authenticated-orcid":false,"given":"Justine","family":"Maller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2360-8556","authenticated-orcid":false,"given":"Emily","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.T.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Sertial","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5854-0216","authenticated-orcid":false,"given":"Kevin","family":"Baszis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2310-7930","authenticated-orcid":false,"given":"Charlotte","family":"Borocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3489-1756","authenticated-orcid":false,"given":"Sampath","family":"Prahalad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1769-549X","authenticated-orcid":false,"given":"Pierre","family":"Quartier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Reinhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9416-6631","authenticated-orcid":false,"given":"Dieneke","family":"Schonenberg-Meinema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Shipman-Duensing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2496-4296","authenticated-orcid":false,"given":"Maria Teresa","family":"Terreri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5735-9856","authenticated-orcid":false,"given":"Julia","family":"Simard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idit","family":"Lavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Chalom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0523-2292","authenticated-orcid":false,"given":"Devy","family":"Zisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2577-139X","authenticated-orcid":false,"given":"Elizabeth D.","family":"Mellins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2020,6,15]]},"reference":[{"key":"2022102902500915000_48.4.567.1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/271569"},{"key":"2022102902500915000_48.4.567.2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210324"},{"key":"2022102902500915000_48.4.567.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1205099"},{"key":"2022102902500915000_48.4.567.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112802"},{"key":"2022102902500915000_48.4.567.5","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/art.40865","article-title":"Treat-to-target using first-line recombinant interleukin-1 receptor antagonist monotherapy in new-onset systemic juvenile idiopathic arthritis: results from a five year follow-up study","volume":"71","author":"Ter Haar","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2022102902500915000_48.4.567.6","doi-asserted-by":"publisher","DOI":"10.2165\/11532610-000000000-00000"},{"key":"2022102902500915000_48.4.567.7","first-page":"657","article-title":"Gastrointestinal symptoms and permeability in patients with juvenile idiopathic arthritis","volume":"21","author":"Weber","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"2022102902500915000_48.4.567.8","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq136"},{"key":"2022102902500915000_48.4.567.9","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100809"},{"key":"2022102902500915000_48.4.567.10","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140472"},{"key":"2022102902500915000_48.4.567.11","doi-asserted-by":"publisher","DOI":"10.1203\/PDR.0b013e31819dbd0a"},{"key":"2022102902500915000_48.4.567.12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13073-018-0558-x","article-title":"Disease-specific regulation of gene expression in a comparative analysis of juvenile idiopathic arthritis and inflammatory bowel disease","volume":"10","author":"Mo","year":"2018","journal-title":"Genome Med"},{"key":"2022102902500915000_48.4.567.13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/art.41107","article-title":"Innately adaptive or truly autoimmune: is there something unique about systemic juvenile idiopathic arthritis?","volume":"72","author":"Kessel","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2022102902500915000_48.4.567.14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12969-017-0160-6","article-title":"The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months","volume":"15","author":"Beukelman","year":"2017","journal-title":"Pediatr Rheumatol Online J"},{"key":"2022102902500915000_48.4.567.15","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150997"},{"key":"2022102902500915000_48.4.567.16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12969-017-0147-3","article-title":"Inflammatory bowel disease following anti-interleukin-1-treatment in systemic juvenile idiopathic arthritis","volume":"15","author":"H\u00fcgle","year":"2017","journal-title":"Pediatr Rheumatol Online J"},{"key":"2022102902500915000_48.4.567.17","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2014.991752"},{"key":"2022102902500915000_48.4.567.18","doi-asserted-by":"publisher","DOI":"10.1002\/art.11300"},{"key":"2022102902500915000_48.4.567.19","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1002\/art.39796","article-title":"Outcome and Trends in Treatment of Systemic Juvenile Idiopathic Arthritis in the German National Pediatric Rheumatologic Database, 2000\u20132013","volume":"68","author":"Klotsche","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2022102902500915000_48.4.567.20","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/jamapediatrics.2015.1982","article-title":"Inflammatory bowel disease in children and adolescents","volume":"169","author":"Rosen","year":"2015","journal-title":"JAMA Pediatr"},{"key":"2022102902500915000_48.4.567.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32448-0"},{"key":"2022102902500915000_48.4.567.22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/apt.15370","article-title":"Increased risk of developing Crohn\u2019s disease or ulcerative colitis in 17 018 patients while under treatment with anti-TNF\u03b1 agents, particularly etanercept, for autoimmune diseases other than inflammatory bowel disease","volume":"50","author":"Korzenik","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"2022102902500915000_48.4.567.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2013.06.005"},{"key":"2022102902500915000_48.4.567.24","doi-asserted-by":"publisher","DOI":"10.1038\/nri3661"},{"key":"2022102902500915000_48.4.567.25","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1172\/JCI124884","article-title":"IFN-\u03b3 drives inflammatory bowel disease pathogenesis through VE-cadherin-directed vascular barrier disruption","volume":"129","author":"Langer","year":"2019","journal-title":"J Clin Invest"},{"key":"2022102902500915000_48.4.567.26","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.134254"},{"key":"2022102902500915000_48.4.567.27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2739\/kurumemedj.45.33","article-title":"Increased circulating levels of interleukin-1 receptor antagonist in patients with inflammatory bowel disease","volume":"45","author":"Kuboyama","year":"1998","journal-title":"Kurume Med J"},{"key":"2022102902500915000_48.4.567.28","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.18632\/oncotarget.26894","article-title":"Interleukin 1 is a key driver of inflammatory bowel disease-demonstration in a murine IL-1Ra knockout model","volume":"10","author":"Dosh","year":"2019","journal-title":"Oncotarget Impact Journals"},{"key":"2022102902500915000_48.4.567.29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01266"},{"key":"2022102902500915000_48.4.567.30","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2011.68"},{"key":"2022102902500915000_48.4.567.31","doi-asserted-by":"crossref","first-page":"e132508","DOI":"10.1172\/jci.insight.132508","article-title":"Th17 reprogramming of T cells in systemic juvenile idiopathic arthritis","volume":"5","author":"Henderson","year":"2020","journal-title":"JCI Insight"},{"key":"2022102902500915000_48.4.567.32","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00011-014-0768-7","article-title":"Elevated levels of Th17 cells and Th17-related cytokines are associated with disease activity in patients with inflammatory bowel disease","volume":"63","author":"Jiang","year":"2014","journal-title":"Inflamm Res"},{"key":"2022102902500915000_48.4.567.33","doi-asserted-by":"crossref","first-page":"e0168276","DOI":"10.1371\/journal.pone.0168276","article-title":"Functional analyses of the Crohn\u2019s disease risk gene LACC1","volume":"11","author":"Assadi","year":"2016","journal-title":"PLoS One"},{"key":"2022102902500915000_48.4.567.34","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3532"},{"key":"2022102902500915000_48.4.567.35","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-307859"},{"key":"2022102902500915000_48.4.567.36","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/art.38877","article-title":"Association of a mutation in LACC1 with a monogenic form of systemic juvenile idiopathic arthritis","volume":"67","author":"Wakil","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2022102902500915000_48.4.567.37","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800636"},{"key":"2022102902500915000_48.4.567.38","doi-asserted-by":"publisher","DOI":"10.1038\/ng.717"},{"key":"2022102902500915000_48.4.567.39","doi-asserted-by":"publisher","DOI":"10.1038\/nature11582"},{"key":"2022102902500915000_48.4.567.40","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3359"},{"key":"2022102902500915000_48.4.567.41","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/gene.2016.17","article-title":"LACC1 polymorphisms in inflammatory bowel disease and juvenile idiopathic arthritis","volume":"17","author":"Assadi","year":"2016","journal-title":"Genes Immun"},{"key":"2022102902500915000_48.4.567.42","first-page":"1133","article-title":"Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis","volume":"34","author":"Behrens","year":"2007","journal-title":"J Rheumatol"},{"key":"2022102902500915000_48.4.567.43","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2012.3"},{"key":"2022102902500915000_48.4.567.44","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-209020"},{"key":"2022102902500915000_48.4.567.45","first-page":"935","article-title":"Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis","volume":"32","author":"Kimura","year":"2005","journal-title":"J Rheumatol"},{"key":"2022102902500915000_48.4.567.46","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090952"},{"key":"2022102902500915000_48.4.567.47","first-page":"220","article-title":"Systemic onset juvenile idiopathic arthritis: a retrospective study of 80 consecutive patients followed for 10 years","volume":"28","author":"Lovell","year":"2001","journal-title":"J Rheumatol"},{"key":"2022102902500915000_48.4.567.48","doi-asserted-by":"publisher","DOI":"10.1002\/art.21774"},{"key":"2022102902500915000_48.4.567.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2004.01.002"},{"key":"2022102902500915000_48.4.567.50","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.200230","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T09:50:34Z","timestamp":1667037034000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.200230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,15]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4,1]]},"published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.3899\/jrheum.200230"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.200230","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,15]]}}}